What is the most recent earnings date for UNCY stock?
UNICYCIVE THERAPEUTICS INC (UNCY) last reported earnings on 3/26/2026.
NASDAQ:UNCY • US90466Y2028
Past quarterly earnings results for UNICYCIVE THERAPEUTICS INC (UNCY), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.33 | -0.57 | 41.88% | 34.00% | - | - | ||
| Q2 2025 | -0.52 | -0.75 | 31.11% | 65.33% | - | - | ||
| Q1 2025 | -0.50 | -1.16 | 56.75% | 91.80% | - | - | ||
| Q4 2024 | -2.60 | -0.92 | -183.22% | -18.18% | - | - | ||
| Q3 2024 | -0.50 | -1.55 | 67.68% | 61.54% | - | - | ||
| Q2 2024 | -1.50 | -1.96 | 23.27% | 48.28% | - | - | ||
| Q1 2024 | -6.10 | -1.58 | -285.83% | 37.11% | - | -100.00% | ||
| Q4 2023 | -2.20 | -1.71 | -28.77% | 37.14% | - | - | ||
| Q3 2023 | -1.30 | -1.22 | -6.21% | 64.86% | - | -100.00% | ||
| Q2 2023 | -2.90 | -3.47 | 16.38% | -20.83% | - | - | ||
| Q1 2023 | -9.70 | -3.80 | -155.30% | -304.17% | 675K | 382.5K | 76.47% | - |
| Q4 2022 | -3.50 | -2.49 | -40.63% | -45.83% | - | - | ||
| Q3 2022 | -3.70 | -2.86 | -29.55% | -362.50% | 950K | - | - | |
| Q2 2022 | -2.40 | -2.31 | -3.80% | -84.62% | - | - | ||
| Q1 2022 | -2.40 | -1.68 | -42.60% | - | - | - | ||
| Q4 2021 | -2.40 | -1.38 | -74.29% | - | - | - | ||
| Q3 2021 | -0.80 | -1.07 | 25.30% | - | - | - | ||
| Q2 2021 | -1.30 | -1.12 | -15.86% | - | - | - | ||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
UNICYCIVE THERAPEUTICS INC (UNCY) last reported earnings on 3/26/2026.
UNICYCIVE THERAPEUTICS INC (UNCY) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, UNICYCIVE THERAPEUTICS INC (UNCY) has beaten EPS estimates in 3 out of 4 releases.